The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Flow Cytometry Services Market by Type of General Flow Cytometric Services (Assay Development and Consumables Manufacturing), Type of Analysis based Flow Cytometric Services (PBMC Analysis, Whole Blood Cells Analysis, Bone Marrow Aspirate Analysis, Stem Cells Analysis, Rare Cells Detection, Cell Profiling and Subsetting and Intracellular Staining), Other types of Flow Cytometric Services, Type of Accreditations (Government and Third-Party Accreditations), Key Players, and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    February 2022

  • Pages
    230

  • View Count
    1554

Example Insights

Flow-Cytomtery-Services-Market-Context Flow-Cytomtery-Services-Market-Service-Providers Flow-Cytomtery-Services-Market-Year-of-Establishment
Flow-Cytomtery-Services-Market-Cytometer-Manufacturers Flow-Cytomtery-Services-Market-Location-of-Facilities Flow-Cytomtery-Services-Market-Competitiveness-Analysis
Flow-Cytomtery-Services-Market-Partnerships-and-Collaborations Flow-Cytomtery-Services-Market-Market-Scenario  

 

Overview

First introduced in 1950s, the flow cytometry technique has gained significant attention in the past few decades. This can be attributed to the fact that flow cytometry has been demonstrated to be capable of overcoming various challenges associated with conventional analytical techniques, such as western blotting and immunohistochemistry. The key concerns related to traditional approaches include low specificity and sensitivity, time and cost intensive procedures, higher chances of producing false results. Specifically, flow cytometry offers several advantages over the conventional methods intended for single cell analysis. For instance, using microscopy, about 6 parameters of a single cell can be detected, whereas a flow cytometer enables the detection of up to 30 distinct parameters. In addition, the modern flow cytometer is capable of processing over 10,000 cells per second, thereby, enabling scientists to rapidly analyze and characterize millions of cells. Currently, flow cytometry is used in a number of applications in the medical industry, including assisting in evaluation of autoimmune disorders and infectious diseases, and diagnosis of leukemia and lymphoma. The increasing prevalence of chronic conditions has led to a rise in the number of focused research efforts being carried out; this has further created a considerable demand for advanced and rapid analytical techniques to better understand the disease morphology. In this context, the adoption of flow cytometry technique has witnessed considerable growth. However, this approach often requires the use of complex and expensive instruments, which need to be operated by highly trained professionals. Several small and mid-sized players usually do not have the resources to make such exorbitant investments. Therefore, outsourcing has emerged as a preferred operational model for flow cytometry innovators, who rely on specialty contract service providers to handle various aspects of flow cytometry related services. 

At present, 30 players claim to offer a range of flow cytometry related services, including customized assay development services, manufacturing of consumables (such as dyes and buffers) used for analysis, analysis of various immune cells for various clinical and non-clinical studies, and cell line development. Further, 25 companies are currently engaged in the manufacturing of novel and advanced flow cytometers. To keep pace with the increasing demand for such services, players are not only actively undertaking initiatives to improve / expand their existing offerings but also entering into strategic partnerships with several industry stakeholders to broaden their respective services portfolios. For instance, in April 2021, Agilex Biolabs acquired TetraQ in order to further broaden its portfolio for analytical services offered via flow cytometry. Driven by the increasing number of clinical studies focused on evaluating treatment modalities against chronic disorders, we believe that the flow cytometry services market is likely to evolve at a steady pace in the foreseen future.

Scope of the Report

The “Flow Cytometry Services Market by Type of General Flow Cytometric Services (Assay Development and Consumables Manufacturing), Type of Analysis based Flow Cytometric Services (PBMC Analysis, Whole Blood Cells Analysis, Bone Marrow Aspirate Analysis, Stem Cells Analysis, Rare Cells Detection, Cell Profiling and Subsetting and Intracellular Staining), Other types of Flow Cytometric Services, Type of Accreditations (Government and Third-Party Accreditations), Key Players, and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035”, report features an extensive study on the current market landscape, offering an informed opinion on the likely evolution of flow cytometry service providers market, in the mid to long term. The study includes an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the report includes:

  • A detailed review of the overall market landscape of the flow cytometry service providers, based on several relevant parameters, such as year of establishment, company size, location of headquarters, location of flow cytometry facilities, type of service(s) offered (general services, analysis services and other flow cytometric services). In addition, the chapter also provides information on the manufacturers and the respective flow cytometry equipment developed / being developed by them. 
  • A detailed competitiveness analysis of the flow cytometry service providers based across different geographies, by taking into consideration their service strength (based on number of services offered), accreditations (based on number of government and third-party accreditations) and supplier strength (based on total years of experience in the industry and company size).
  • Tabulated profiles of key players offering services related to flow cytometry, based across various geographies. Each profile includes a brief overview of the company, financial information (if available), details on its services portfolio, types of services offered, location of flow cytometry facilities, recent developments and an informed future outlook. 
  • An analysis of the partnerships that have been inked by various stakeholders engaged in the field of flow cytometry, during the period 2011-2021, covering product development agreements, research and development agreements, licensing agreements, product commercialization agreements, platform utilization agreement, technology integration agreements and other relevant types of deals. 

One of the key objectives of the report was to identify the primary growth drivers and estimate the future growth opportunity associated with the flow cytometry services market. We have provided an informed estimate of the evolution of the market for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of region (North America, Europe and Asia-Pacific). In order to account for the uncertainties and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The opinions and insights presented in the report are backed by a deep understanding of key insights generated from our secondary research. 
All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the leading players offering services related to flow cytometry?
  • What is the relative competitiveness of the players offering services related to flow cytometry, based across different geographies?
  • What are the type of services being offered by players engaged in the field of flow cytometry?
  • What are the key trends in the flow cytometry service providers market?
  • What kind of initiatives are being taken by stakeholders engaged in the flow cytometry domain?
  • How is the current and future opportunity likely to be distributed across key market segments?
  • What are the anticipated future trends related to the flow cytometry services market?

Contents

Chapter Outlines

Chapter 1 is an executive summary of the insights captured in our research. It offers a high-level view on the current state of the flow cytometry services market and its likely evolution in the mid to long term.

Chapter 2 provides a general introduction to flow cytometry and types of flow cytometers. In addition, the chapter highlights the importance of flow cytometry and challenges associated with the use of flow cytometers. Further, it provides a brief introduction on the types of services offered by the players, discussing the role of contract service providers in the field of flow cytometry, prevalent outsourcing trends and future perspectives.

Chapter 3 provides an overview of the overall market landscape of flow cytometry service providers, featuring a list of around 30 stakeholders and a detailed analysis based on several parameters, such as year of establishment, company size, location of headquarters, location of flow cytometry facilities, type of general services offered (customized assay development and consumables manufacturing), type of analysis based services offered (PBMC analysis, whole blood cell analysis, bone marrow aspirate analysis, stem cells analysis, intra-cellular staining, rare cell detection and cell profiling and subsetting), other types of flow cytometric services offered and type of accreditations (FDA, EMA, TGA, PMDA and others).

Chapter 4 presents an insightful competitiveness analysis of the flow cytometry service providers based across different geographies, by taking into consideration their service strength (based on number of services offered), supplier strength (based on total years of experience in this industry and company size) and accreditations (based on number of government and third-party accreditations).

Chapter 5 includes tabulated profiles of key players offering services related to flow cytometry, based in North America. Each profile includes a brief overview of the company, financial information (if available), details on its services portfolio, location of flow cytometry facilities, recent developments, and an informed future outlook.

Chapter 6 includes tabulated profiles of key players offering services related to flow cytometry, based in Europe. Each profile includes a brief overview of the company, financial information (if available), details on its services portfolio, location of flow cytometry facilities, recent developments, and an informed future outlook.

Chapter 7 includes tabulated profiles of key players offering services related to flow cytometry, based in the Asia-Pacific region. Each profile includes a brief overview of the company, financial information (if available), details on its services portfolio, location of flow cytometry facilities, recent developments, and an informed future outlook.

Chapter 8 features a detailed analysis of the partnerships and collaborations that have been inked in this domain since 2011, covering product development agreements, research and development agreements, licensing agreements, product commercialization agreements, platform utilization agreements, technology integration agreements and other relevant types of deals.
 
Chapter 9 features an in-depth efficiency comparison analysis of seven analogous conventional techniques of flow cytometry, on the basis of important parameters, such as analytical strength, time duration score and accuracy strength. 

Chapter 10 presents an insightful market forecast analysis, highlighting the likely growth of the flow cytometry services market for the period, 2022-2035. In order to provide a detailed future outlook, our year-wise projections of the current and future opportunity have further been segmented on the basis of region (North America, Europe and Asia-Pacific). 

Chapter 11 is a summary of the overall report, presenting key insights on the contemporary market trends and the likely evolution of the flow cytometry services market. 

Chapter 12 is an appendix that contains tabulated data and numbers for all the figures in the report.

Chapter 13 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Flow Cytometry
3.3. Flow Cytometry Versus Conventional Analytical Techniques
3.4. Difference between Flow Cytometer, Cell Analyzer and Cell Sorter
3.5. Flow Cytometry Instrumentation
3.5.1. Flow Cytometry Technologies
3.5.2. Flow Cytometry: Cell Analyzing and Counting Methodology
3.5.3. Flow Cytometry: Software and Automation Support

3.6. Flow Cytometry Services
3.6.1 Flow Cytometric Analysis
3.6.2. Flow Cytometric Consumables and Assay Development
3.7 Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Flow Cytometry Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region wise Distribution of Companies
4.2.4. Analysis by Location of Flow Cytometry Facilities
4.3. Analysis by Type(s) of Service Offered
4.3.1. Analysis by Type(s) of Flow Cytometric Services Offered
4.3.2. Analysis by Type(s) of Analytical Flow Cytometric Services Offered
4.4. Analysis by Type(s) of Instrument Providers

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Key Parameters
5.4. Competitiveness Analysis: Flow Cytometry Service Providers
5.4.1. Flow Cytometry Service Providers in North America
5.4.2 Flow Cytometry Service Providers in Europe and Asia-Pacific

6. COMPANY PROFILES: FLOW CYTOMETRY SERVICE PROVIDERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. FlowMetric Life Sciences
6.2.1. Company Overview
6.2.2. Flow Cytometry Services Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Flow Contract Sites Laboratory
6.3.1. Company Overview
6.3.2. Flow Cytometry Services Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. Bio-Legend
6.4.1. Company Overview
6.4.2. Flow Cytometry Services Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Q2 Solutions
6.5.1. Company Overview
6.5.2. Flow Cytometry Services Portfolio
6.5.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: FLOW CYTOMETRY SERVICE PROVIDERS IN EUROPE
7.1. Chapter Overview
7.2. ProImmune
7.2.1. Company Overview
7.2.2. Flow Cytometry Services Portfolio
7.2.3. Recent Developments and Future Outlook

7.3. MLM Medical Labs
7.3.1. Company Overview
7.3.2. Flow Cytometry Services Portfolio
7.3.3. Recent Developments and Future Outlook

7.4. Unilabs
7.4.1. Company Overview
7.4.2. Flow Cytometry Services Portfolio
7.4.3. Recent Developments and Future Outlook

7.5. Firalis
7.5.1. Company Overview
7.5.2. Flow Cytometry Services Portfolio
7.5.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: FLOW CYTOMETRY SERVICE PROVIDERS IN ASIA-PACIFIC
8.1. Agilex Biolabs
8.1.1. Company Overview
8.1.2. Flow Cytometry Services Portfolio
8.1.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.2.1. Flow Cytometry Service Providers: List of Partnerships and Collaborations
9.2.2. Analysis by Year of Partnership
9.2.3. Analysis by Type of Partnership
9.2.4. Analysis by Type of Partner
9.3. Flow Cytometry Service Providers: Information on Type of Service(s) Offered
9.3.1. Analysis by Type of Service Offered
9.3.2. Analysis by Type of Service Offered and Type of Partnership
9.3.3. Most of Active Players: Analysis by Number of Partnerships
9.3.4. Top Partners: Analysis by Number of Partnerships
9.3.5. Geographical Analysis: Intercontinental and Intracontinental Agreements

10. EFFICIENCY COMPARISON MODULE
10.1 Chapter Overview
10.2 Methodology
10.3 Key Parameters
10.4 Flow Cytometry Efficiency Comparison Analysis
10.5 Inclusive Efficiency Comparison Analysis
10.6 Efficiency Comparison Analysis
10.6.1 Flow Cytometry vs Immunohistochemistry
10.6.2 Flow Cytometry and Cytogenetics Testing
10.6.3 Flow Cytometry and Fluorescence Microscopy
10.6.4 Flow Cytometry and ELISA
10.6.5 Flow Cytometry and Western Blotting
10.6.6 Flow Cytometry and Hematology Cell Analyzer
10.6.7 Flow Cytometry and Dynabead Method
10.7 Concluding Remarks

11. MARKET FORECAST
11.1 Chapter Overview
11.2 Forecast Methodology and Key Assumptions
11.3 Flow Cytometry Services Market in North America, 2022-2035
11.4 Flow Cytometry Services Market in Europe, 2022-2035
11.5 Flow Cytometry Services Market in Asia-Pacific, 2022-2035

12. CONCLUDING REMARKS
12.1. Chapter Overview

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Working Mechanism of Flow Cytometry
Figure 3.2 Difference between Flow Cytometer, Cell Analyzer and Cell Sorter
Figure 3.3 Flow Cytometry: Based on Type of Technology
Figure 3.4 Services related to Flow Cytometry
Figure 4.1 Flow Cytometry Service Providers: Distribution by Year of Establishment
Figure 4.2 Flow Cytometry Service Providers: Distribution by Company Size
Figure 4.3 Flow Cytometry Service Providers: Region wise Distribution of Companies
Figure 4.4 Flow Cytometry Service Providers: Distribution by Location of Flow Cytometry Facilities
Figure 4.5 Flow Cytometry Service Providers: Distribution by Type of Services Offered
Figure 4.6 Flow Cytometry Service Providers: Distribution by Type of General Flow Cytometry Services Offered
Figure 4.7 Flow Cytometry Service Providers: Distribution by Type of Analysis based Flow Cytometry Services Offered
Figure 4.8 Flow Cytometry Service Providers: Distribution by Type of Instrument Used
Figure 5.1 Company Competitiveness Analysis: Flow Cytometry Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: Flow Cytometry Service Providers in Europe and Asia Pacific
Figure 9.1 Partnerships and Collaborations: Cumulative Year Wise Trend: 2010-2021 (till July)
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2010-2021 (till July)
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Service Offered
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Service Offered and Type of Partnership
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Top Partners: Distribution by Number of Partnerships
Figure 9.9 Partnerships and Collaborations: Geographical Analysis
Figure 9.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements

List Of Tables

Table 4.1 Flow Cytometry Service Providers: List of Companies
Table 4.2 Flow Cytometry Services Providers: Type of Service(s) Offered
Table 6.1 Flow Cytometry Service Providers in North America: List of Companies Profiled
Table 6.2 Flowmetric Life Sciences: Company Snapshot
Table 6.3 Flowmetric Life Sciences: Services Portfolio
Table 6.4 Flowmetric Life Sciences: Recent Developments and Future Outlook
Table 6.5 Flow Contract Site Laboratories: Company Snapshot
Table 6.6 Flow Contract Site Laboratories: Services Portfolio
Table 6.7 Flow Contract Site Laboratories: Recent Developments and Future Outlook
Table 6.8 Bio-Legend: Company Snapshot
Table 6.9 Bio-Legend: Services Portfolio
Table 6.10 Bio-Legend: Recent Developments and Future Outlook
Table 6.11 Q2 Solutions: Company Snapshot
Table 6.12 Q2 Solutions: Services Portfolio
Table 6.13 Q2 Solutions: Recent Developments and Future Outlook
Table 7.1 Flow Cytometry Service Providers in Europe: List of Companies Profiled
Table 7.2 ProImmune: Company Snapshot
Table 7.3 ProImmune: Services Portfolio
Table 7.4 ProImmune: Recent Developments and Future Outlook
Table 7.5 MLM Medical Labs: Company Snapshot
Table 7.6 MLM Medical Labs: Services Portfolio
Table 7.7 MLM Medical Labs: Recent Developments and Future Outlook
Table 7.8 Unilabs: Company Snapshot
Table 7.9 Unilabs: Services Portfolio
Table 7.10 Unilabs: Recent Developments and Future Outlook
Table 7.11 Firalis: Company Snapshot
Table 7.12 Firalis: Services Portfolio
Table 7.13 Firalis: Recent Developments and Future Outlook
Table 8.1 Flow Cytometry Service Providers in Asia-Pacific: List of Companies Profiled
Table 8.2 Agilex Biolabs: Company Snapshot
Table 8.3 Agilex Biolabs: Services Portfolio
Table 8.4 Agilex Biolabs: Recent Developments and Future Outlook
Table 9.1 Flow Cytometry Service Providers: List of Partnerships and Collaborations
Table 9.2 Flow Cytometry Service Providers: Information on Type of Service(s) offered

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. ABS Laboratories
  2. Accelix
  3. Accuri Cytometers
  4. ACEA Bioscience (Acquired by Agilent Technologies)
  5. ACM Global Laboratories
  6. Affymetrix (Acquired by Thermofisher Scientific)
  7. Agilent Technologies
  8. Agilex Biolabs
  9. AH diagnostics
  10. Akadeum Life Science 
  11. AllCells 
  12. Alverno Laboratories
  13. Amphasys
  14. ApogeeFlow
  15. BD
  16. Beckman Coulter
  17. Bio Legend
  18. bioMérieux
  19. Bio-Rad laboratories
  20. Blue Ocean Biomedical (Acquired by Beckman Coulter)
  21. Bucher Biotec
  22. Caprion Biosciences
  23. CellCarta 
  24. Cellular Research
  25. CirQuest Labs (Acquired by MLM Medical Labs)
  26. Clearstone Central Laboratories
  27. CSI Laboratories
  28. Cytek Bioscience s
  29. Cytobank
  30. Cytognos
  31. Cytonome
  32. Cytonome
  33. DAON Biosciences
  34. De Novo Software
  35. Discovery and Drug Development Solutions (Division of Merck Millipore)
  36. Discovery Life Sciences
  37. EMBL
  38. Eurofins Bioanalytical Services
  39. Filgen
  40. Firalis
  41. Flow Contract Site Laboratory (FCSL)
  42. Flow Jo 
  43. Flow Paradigm
  44. FlowMetric Life Sciences
  45. Genoptix
  46. Handeym
  47. Hematogenix
  48. HepaTX 
  49. I&L Biosystems
  50. ICON Speciality Labs (formerly known as MolecularMD)
  51. iCyt Mission Technology
  52. Inabata
  53. IncellDX 
  54. Invetech
  55. Invitrx Therapeutics
  56. KCAS Bioanlytical and Biomarker Services
  57. LabClinics
  58. LabCorp Drug Development
  59. Luminex
  60. Luxcel Biosciences
  61. Massachusetts General Hospital
  62. MD Biosciences
  63. Millenium Science
  64. Millipore Sigma
  65. Miltenyi Biotech
  66. Miltenyi Imaging (formerly known as Sensovation)  
  67. MLM Medicine Labs
  68. Molecular Device
  69. Molecular MD
  70. Molecular Pathology Laboratory Network
  71. Myriad RBM
  72. Namocell
  73. NanoCellect Biomedical
  74. NanoFCM 
  75. NeoGenomics Laboratories
  76. Nexcelom Bioscience
  77. Novogene
  78. Omega Biosystem (Acquired by California NanoSystems Institute)
  79. Omni Life Science
  80. On-Chip Biotechnologies
  81. Owl Biomedical
  82. Parnassus Flow Cytometry Core facility, University of California
  83. PHC Holdings
  84. Phitonex (Acquired by Thermofisher Scientific)
  85. ProImmune
  86. Propel Labs
  87. Q2 Solutions 
  88. QualTek Molecular Laboratories (Acquired by Discovery Life Sciences)
  89. RAMCON
  90. RayBiotech
  91. ReachBio
  92. Real Matrix
  93. rqmicro 
  94. Saltro (Acquired by Unilabs)
  95. Sartorius Stedim Biotech
  96. SBT Instruments
  97. Sirigen (Acquired by BD)
  98. Sony Biotechnology
  99. Stanford University
  100. Stratedigm
  101. Sumitomo Dainippon Pharma
  102. Suzhou Hybiome Biomedical Engineering
  103. Sysmex Inostics (Subsidiary of Sysmex)
  104. Sysmex Partec
  105. Takara Bio
  106. Terso Solutions
  107. TetraQ
  108. Texcell
  109. Thermo Fisher Scientific
  110. Tomy Digital Biology
  111. Unilabs
  112. Wyatt Technology
  113. Xitogen Technologies (Acquired by Beckman Coulter)

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com